World’s First Gene Therapy for Glycogen Storage Disease Produces Remarkable Results
The clinical trial originally set out to simply test the safety and dosage of the gene therapy for three patients with GSD Type Ia. The dramatic improvement in their lives was unexpected.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
